DS(600694)
Search documents
大商股份(600694) - 大商股份有限公司对外担保管理办法(2025年12月修订)
2025-12-05 11:47
大商股份有限公司对外担保管理办法 大商股份有限公司 对外担保管理办法 (2025 年 12 月修订) 第一章 总则 第一条 为了保护投资人的合法权益,规范大商股份有限公司(以下 简称"公司")的对外担保行为,有效防范公司对外担保风险,确保公司资产安 全,促进公司健康稳定发展,根据《中华人民共和国公司法》(以下简称"《公 司法》")、《中华人民共和国民法典》(以下简称"《民法典》")、《上市 公司监管指引第8号——上市公司资金往来、对外担保的监管要求》《上海证券 交易所股票上市规则》等法律法规、规范性文件和《大商股份有限公司章程》(以 下简称"《公司章程》")的有关规定,结合公司的实际情况,制定本管理办法。 第二条 本办法所称对外担保是指公司或控股子公司为他人提供的 担保和公司对控股子公司的担保。 第三条 公司对外担保实行统一管理,非经公司董事会或股东会批准, 任何人无权以公司名义签署对外担保的合同、协议或其他类似的法律文件。 第四条 公司控股子公司的对外担保,视同公司行为,其对外担保应 执行本制度。 第五条 公司为他人提供担保,应当采取反担保等必要的措施防范风 险,谨慎判断反担保提供方的实际担保能力和反担保的 ...
大商股份:王雪艳当选为职工代表董事
Mei Ri Jing Ji Xin Wen· 2025-12-05 11:47
截至发稿,大商股份市值为60亿元。 2024年1至12月份,大商股份的营业收入构成为:其他业务占比51.92%,超市业态占比24.45%,家电连 锁业态占比15.42%,其他占比8.22%。 (记者 曾健辉) 每经头条(nbdtoutiao)——秒光、售罄!银行大额存单成稀缺资源,2%以上产品很难抢,有的门槛高 达1000万元!专家:存款利率或长期下行 每经AI快讯,大商股份(SH 600694,收盘价:17.26元)12月5日晚间发布公告称,鉴于公司经营管理 和工作安排需要,邢裕奇辞去公司职工董事及董事会下设审计委员会、战略委员会委员职务。经与会职 工代表推举并表决通过,同意选举王雪艳为公司第十二届董事会职工代表董事,并接任邢裕奇在董事会 各专业委员会中的全部职务,任期至本届董事会届满之日止。 ...
大商股份(600694) - 大商股份有限公司关于公司变更职工董事的公告
2025-12-05 11:46
(二) 离任对公司的影响 根据《中华人民共和国公司法》(以下简称"《公司法》")《大商股份有限公 司章程》(以下简称"《公司章程》")的有关规定,邢裕奇的辞职未导致公司董事 会成员低于法定最低人数,不会影响公司董事会正常运作。邢裕奇将按照相关规 定做好交接工作,其不存在未履行完毕的公开承诺。公司及公司董事会对邢裕奇 在任职期间所做出的贡献表示衷心的感谢! 证券代码:600694 证券简称:大商股份 公告编号:2025-057 大商股份有限公司 关于公司变更职工董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 鉴于公司经营管理和工作安排需要,邢裕奇辞去公司职工董事及董事会下设 审计委员会、战略委员会委员职务。公司于 2025 年 12 月 5 日召开职工代表大会。 经与会职工代表推举并表决通过,同意选举王雪艳为公司第十二届董事会职工代 表董事(简历后附),并接任邢裕奇在董事会各专业委员会中的全部职务,任期 至本届董事会届满之日止。 一、董事离任情况 | | | | | | | | | | | | | 是 ...
大商股份(600694) - 大商股份有限公司关于修订《公司章程》及公司治理制度的公告
2025-12-05 11:46
证券代码:600694 证券简称:大商股份 编号:2025-055 大商股份有限公司 关于修订《公司章程》及公司治理制度的公告 本次修订《公司章程》尚需提交股东会审议,并在公司股东会审议通过后, 授权董事会、管理层办理本次《公司章程》变更等相关事宜。 二、公司治理制度的修订、制定情况 根据最新修订后的《公司章程》,拟同步对公司治理制度作出修订,具体情 况如下: | | 制度名称 | 是否提交 股东会审议 | | --- | --- | --- | | 1 | 大商股份有限公司章程 | 是 | | 2 | 大商股份有限公司董事会议事规则 | 是 | | 3 | 大商股份有限公司董事会提名委员会工作细则 | 否 | | 4 | 大商股份有限公司董事会薪酬与考核委员会工作细则 | 否 | | 5 | 大商股份有限公司 CEO 工作制度 | 否 | | 6 | 大商股份有限公司投资者关系管理工作制度 | 否 | 1 | | 制度名称 | 是否提交 股东会审议 | | --- | --- | --- | | 7 | 大商股份有限公司信息披露管理工作制度 | 否 | | 8 | 大商股份有限公司重大信息内部报告制度 | ...
大商股份(600694) - 大商股份有限公司关于公司补选董事及聘任高级管理人员的公告
2025-12-05 11:46
证券代码:600694 证券简称:大商股份 公告编号:2025-054 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 大商股份有限公司(以下简称"公司")董事会于 2025 年 12 月 5 日召开第 十二届董事会第六次会议。鉴于公司经营管理和工作安排需要,经董事会提名委 员会审核、董事会审议通过,提名吕伟顺、刘晶、高长明为公司第十二届董事会 非独立董事候选人;聘任刘晶为公司总经理;聘任宋晓静、张涛、梁特、谢雪霞 为公司副总经理。经董事会提名委员会、审计委员会审核及董事会审议通过,闫 莉不再担任财务负责人,聘任宋晓静为财务负责人。现将相关情况公告如下: 一、董事及高级管理人员离任情况 (一) 提前离任的基本情况 | 姓名 | 离任职务 | | 离任时间 | | 原定任期到期日 | | 离任原因 | 是否继续在 上市公司及 其控股子公 司任职 | 是否存 在未履 行完毕 的公开 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | ...
大商股份(600694) - 大商股份有限公司关于召开2025年第四次临时股东会的通知
2025-12-05 11:45
证券代码:600694 证券简称:大商股份 公告编号:2025-056 大商股份有限公司 采用上海证券交易所网络投票系统,通过交易系统投票平台的投票 时间为股东会召开当日的交易时间段,即 9:15-9:25,9:30-11:30, 13:00-15:00;通过互联网投票平台的投票时间为股东会召开当日的 9:15-15:00。 (六) 融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 股东会召开日期:2025年12月22日 本次股东会采用的网络投票系统:上海证券交易所股东会网络投票系统 (一) 股东会类型和届次 2025年第四次临时股东会 (二) 股东会召集人:董事会 (三) 投票方式:本次股东会所采用的表决方式是现场投票和网络投票相结合 的方式 (四) 现场会议召开的日期、时间和地点 召开的日期时间:2025 年 12 月 22 日 9 点 30 分 召开地点:大连市中山区青三街 1 号公司总部 1902 会议室 (五) 网络投票的系统、起止日期和投票时间。 网络投票系统:上海证券交易所股东会网络投票系统 网络投票起止时间:自2025 年 12 月 22 日 关于召开2025年第四次临时股东会的通知 ...
11月18家A股公司筹划赴港上市,中际旭创拟发行H股





Bei Ke Cai Jing· 2025-11-29 02:59
Core Viewpoint - The trend of A-share companies planning to list in Hong Kong continues, with 18 companies disclosing their intentions to issue H-shares and list on the Hong Kong Stock Exchange in November [1] Group 1: Companies Planning to List - 18 A-share listed companies have announced plans to issue H-shares and list in Hong Kong from November 1 to November 29 [1] - Zhongji Xuchuang announced on November 10 its intention to issue H-shares and list on the Hong Kong Stock Exchange [1] Group 2: Specific Company Announcements - Runjian Co., Ltd. announced on November 25 its plan to issue H-shares and list in Hong Kong [2] - Ningbo Yunsheng authorized management on November 24 to initiate preparations for issuing H-shares and listing in Hong Kong [2] - Igor announced on November 24 its plan to issue H-shares and list in Hong Kong [2] - Miao Exhibition announced on November 24 its intention to issue H-shares and list in Hong Kong [2] - Zhuoyi Information announced on November 20 its plan to issue H-shares and list in Hong Kong [2] - Yuanjie Technology announced on November 19 its intention to issue H-shares and list in Hong Kong [2] - Dashang Co., Ltd. announced on November 18 its plan to issue H-shares and list in Hong Kong [2] - Sifang Jingchuang announced on November 14 its intention to issue H-shares and list on the main board of the Hong Kong Stock Exchange [2] - Zejing Pharmaceutical announced on November 14 its plan to issue H-shares and list in Hong Kong [2] - Juxin Technology announced on November 14 its intention to issue H-shares and list in Hong Kong [2] - Deye Co., Ltd. announced on November 13 its plan to issue H-shares and list in Hong Kong [2] - Tuosida announced on November 12 its intention to issue H-shares and list in Hong Kong [2] - Marumi Bio announced on November 12 its plan to issue H-shares and apply for listing in Hong Kong [2] - Transsion Holdings announced on November 12 its intention to issue H-shares and list in Hong Kong [2] - Anker Innovations announced on November 11 its plan to issue H-shares and list in Hong Kong [2] - Visual China announced on November 4 that it is planning to issue H-shares [2] - Juhe Materials announced on November 3 its plan to issue FF shares and list in Hong Kong [2]
“A+H”双平台助力上市公司高质量发展
Zheng Quan Ri Bao· 2025-11-25 16:21
Core Viewpoint - The recent surge of A-share companies applying for or planning to list in Hong Kong reflects both strategic choices for corporate development and significant progress in the reform of China's capital markets [1] Group 1: A-share Companies' Listing Trends - Over 140 A-share companies have proposed plans for listing in Hong Kong or splitting subsidiaries for a Hong Kong listing this year [1] - The current wave of listings is characterized by leading enterprises and prominent players in niche sectors actively participating [1] Group 2: Strategic Recommendations for Companies - Companies should maintain strategic clarity and prepare adequately to convert opportunities into high-quality development [2] - It is essential to optimize financing structures using the "A+H" dual platform, particularly for companies in emerging industries like new energy, high-end manufacturing, biomedicine, and new consumption [2] - Companies must establish clear capital strategies based on their development stages and needs, avoiding blind following of trends [2] Group 3: Governance and Brand Development - Companies should enhance internal controls and transparency to meet the governance standards of the Hong Kong market, which align with international practices [2] - The listing in Hong Kong should be viewed as an opportunity to build international brands and improve brand reputation and recognition [2] Group 4: Global Operations and Resource Integration - Listing in Hong Kong is seen as a new starting point for integrating global resources rather than an endpoint [3] - Companies are encouraged to attract international strategic investors and engage in cross-border technology and talent cooperation [3] - The "A+H" dual platform model is increasingly favored by quality enterprises, contributing to their high-quality development and the deepening reform of China's capital markets [3]
超140家!“A+H”上市升温
证券时报· 2025-11-25 00:18
Group 1 - The core viewpoint of the article highlights the increasing trend of A-share companies pursuing listings in Hong Kong, with over 140 companies having submitted plans for such listings this year, marking a significant shift towards internationalization and capital market openness [1][4][9] - The listing of companies like HLA Home and Dalian Commodity Exchange reflects a broader strategy for A-share companies to enhance their global presence and financing options, transitioning from "Chinese brands" to "global brands" [1][2][4] - The Hong Kong IPO market has seen a total fundraising amount exceeding 200 billion HKD this year, positioning it as the leading global exchange for IPOs, with major A-share companies like CATL and Hengrui Medicine joining the ranks [4][6] Group 2 - Chinese securities firms are capturing significant market share in the Hong Kong IPO space, accounting for over 60% of the underwriting market, leveraging their extensive resources and familiarity with regulatory frameworks [6][7] - Leading Chinese investment banks, such as CICC and CITIC Securities, are at the forefront of the Hong Kong IPO underwriting rankings, indicating a strong competitive position in the market [7] - The current IPO boom is expected to have a lasting impact on the Chinese securities industry, enhancing their ability to meet cross-border financing needs and improving international competitiveness [7][8] Group 3 - The number of A-share companies seeking to list in Hong Kong is anticipated to remain high, supported by favorable policies and the recent addition of more qualified auditing firms for H-share companies [9] - The article emphasizes that the "A+H" listing trend is driven by a flexible policy environment and the strategic enhancement of company quality, with expectations for continued interest from major A-share companies [9] - The potential for Hong Kong to evolve from a "valuation lowland" to a platform for the internationalization of Chinese assets is highlighted, with a focus on attracting global capital [2][9]
大商股份筹划赴港IPO
Shen Zhen Shang Bao· 2025-11-20 23:30
大商股份在公告中表示,为提升公司国际化品牌形象,同时打造多元化资本运作平台,增强公司的境外 融资能力,进一步提升公司核心竞争力,公司拟在境外发行股份(H股)并在港交所主板挂牌上市,公 司董事会授权公司管理层启动本次H股上市的前期筹备工作。 【深圳商报讯】(记者 钟国斌)大商股份(600694)11月19日公告称,公司11月18日召开第十二届董 事会第五次会议,审议通过了授权公司管理层启动公司H股发行相关筹备工作的议案。 截至目前,公司正积极与相关中介机构就本次H股上市的相关工作进行筹备、商讨,关于本次H股上市 的细节尚未确定。本次H股上市能否通过审议、备案和审核程序并最终实施具有重大不确定性。 大商股份成立于1992年,母公司大商集团是国内最大的零售业集团之一。 ...